Zhuhai Rundu Pharmaceutical Stock Forum

Investors' belief that Zhuhai Rundu Pharmaceutical will underperform the broader market may explain its low P/E ratio. If recent medium-term earnings trends persist, the share price is unlikely to see significant movement soon.